| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
59,420,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
551,455 |
551,455 |
642,217 |
| Total Buy Value |
$0 |
$778,895 |
$778,895 |
$1,265,385 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
7 |
7 |
12 |
| Total Shares Sold |
0 |
4,890 |
11,122 |
27,899 |
| Total Sell Value |
$0 |
$7,922 |
$39,768 |
$125,583 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
2 |
4 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
102,639 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-04-15 |
4 |
D |
$4.50 |
$9,824 |
D/D |
(2,183) |
356,780 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,437 |
358,963 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-04-15 |
4 |
D |
$4.50 |
$9,824 |
D/D |
(2,183) |
224,031 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,437 |
226,214 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-04-15 |
4 |
D |
$4.50 |
$9,824 |
D/D |
(2,183) |
25,877 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,437 |
28,060 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-04-15 |
4 |
D |
$4.50 |
$5,450 |
D/D |
(1,211) |
2,914 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
4,125 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-01-26 |
4 |
AS |
$5.56 |
$14,984 |
D/D |
(2,695) |
0 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$13,148 |
D/D |
(2,578) |
218,777 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
221,355 |
|
- |
|
| Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$7,293 |
D/D |
(1,430) |
98,514 |
|
- |
|
| Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
99,944 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$13,148 |
D/D |
(2,578) |
351,526 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
354,104 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2023-01-15 |
4 |
D |
$5.10 |
$41,422 |
D/D |
(8,122) |
1,239,510 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,438 |
1,247,632 |
|
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$13,148 |
D/D |
(2,578) |
20,623 |
|
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
23,201 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$7,293 |
D/D |
(1,430) |
2,695 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
4,125 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-01-15 |
4 |
D |
$5.10 |
$13,148 |
D/D |
(2,578) |
20,623 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,438 |
23,201 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-01-10 |
4 |
AS |
$4.57 |
$8,523 |
D/D |
(1,865) |
0 |
|
- |
|
293 Records found
|
|
Page 4 of 12 |
|
|
